Benoît Roch - Cancerology Research Institute of Montpellier (IRCM), Institut national de la santé et de la recherche médicale (INSERM) unit U1194, Montpellier, France

基本信息

浏览量：8

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 64 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

An Optimized Next-Generation Sequencing Method for Detecting De Novo MET Amplification in Non-Small Cell Lung Cancer: Prognostic and Therapeutic Implications

Simon Cabello-Aguilar,Julie A Vendrell,Solène Evrard, Quentin Thomas,Benoît Roch,Frédéric Escudié,Isabelle Solassol,Pierre Brousset,Julien Mazières,Jérôme Solassol

Laboratory investigation a journal of technical methods and pathology（2025）

引用0浏览0WOS引用

Prise En Charge Des Cancers Bronchiques À Petites Cellules De Stade Localisé I Actualisation

E. Nicolas, C. Faivre-Finn,E. Giroux Leprieur,S. Ocak,P. Fournel, E. Negre,B. Roch,C. Le Pechoux

Revue des Maladies Respiratoires Actualitésno. 2 (2024): 2S138-2S146

引用0浏览0引用

Optimized NGS-based De Novo MET Amplification Detection for Improved Lung Cancer Patient Management

Simon Cabello-Aguilar,Julie A. Vendrell,Solène Evrard, Quentin Thomas,Benoît Roch,Frédéric Escudié,Isabelle Solassol,Pierre Brousset,Julien Mazières,Jérôme Solassol

crossref（2024）

引用0浏览0引用

Association of Vascular Netosis with COVID-19 Severity in Asymptomatic and Symptomatic Patients

Suman Kapoor,Lucia Mihalovicova,Ekaterina Pisareva,Brice Pastor,Alexia Mirandola,Benoit Roch, Joe Bryant, Anna Philip Princy,Salem Chouaib,Alain Roger Thierry

ISCIENCE（2024）

引用1浏览0WOS引用

164P A Spatially Informed Transcriptomic Model to Forecast Early Resistance to Front-Line Osimertinib in Advanced EGFR-mutant NSCLC

J. Zugazagoitia,G. Ruiz de Garibay, S. Pineda,B. Roch,P. Garrido Lopez,M.D. Isla Casado,I. Vathiotis,C. Aguado,A. Callejo Perez,R. Marse Fabregat,M.R. García Campelo,A. Blasco Cordellat,K. Syrigos,R. Bernabe Caro,O.J. Juan Vidal,E. Conde Gallego, B. Hernando Fuster,G. Macintyre,L.G. Paz-Ares, M. Peressini Álvarez

Annals of Oncology (2024): S281-S282

引用0浏览0引用

1259MO Encorafenib Plus Binimetinib in Patients (pts) with Previously Untreated BRAF V600E-mutant Advanced Non-Small Cell Lung Cancer (NSCLC): an Open-Label, Multicenter Phase II Trial (IFCT-1904 ENCO-BRAF)

D. Planchard,J. Mazieres,C. Mascaux,F. Guisier,P. Tomasini,M. Wislez,D. Moro-Sibilot,S. Cousin,A.B. Cortot,S. Couraud,V. Fallet, C. Guguen, A. Lagrange,A-C. Madroszyk Flandin,J. Otto,M. Pérol,B. Roch,E. Amour,F. Morin,C. Ricordel

Annals of Oncology (2024): S806-S807

引用0浏览0引用

Prognostic Impact of the Number and Total Tumor Burden of Secondary Cerebral Lesions in Patients with Resected Brain Metastases of Non-Small Cell Lung Cancers

Sidonie Sauvageot,Caroline Mollevi, Quentin D. Thomas,Marie Charissoux,Amelie Darlix,Valerie Rigau,Luc Bauchet,Xavier Quantin,Jean Louis Pujol,Benoit Roch,Julien Boetto

JOURNAL OF NEUROSURGERYno. 1 (2024): 89-99

引用2浏览0WOS引用

What Does N2 Lymph Node Involvement Mean for Patients with Non-Small Cell Lung Cancer (NSCLC)?—A Review of Implications for Diagnosis and Treatment

Julio Linares Díaz,John Edwards,Anne-Leen Deleu,Niccolo Giaj-Levra,Elena Prisciandaro,Benoit Roch,Marianne Paesmans,Thierry Berghmans,Mariana Brandão

Cancersno. 15 (2024): 2673

引用0浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn